Maggie Porter, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7627 E 37th St N Apt 802, Wichita, KS 67226 Phone: 316-772-3229 |
Bilingual Speech Therapy Of Kansas Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1999 N Amidon Ave, Ste 110, Wichita, KS 67203 Phone: 316-768-6718 |
Karina Brandt Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8700 E 29th St N, Wichita, KS 67226 Phone: 316-634-8710 |
Darcy Esslinger Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1443 N Melrose Ln, Wichita, KS 67212 Phone: 316-308-7476 |
Janelle Walter, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13213 W 21st Ct Ste 104, Wichita, KS 67235 Phone: 316-573-6802 Fax: 316-721-2291 |
Kathrine Patton Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8700 E 29th St N, Wichita, KS 67226 Phone: 316-634-8700 |
Mrs. Nancy M Crandall, CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 14 E Douglas Pkwy, Wichita, KS 67206 Phone: 316-686-5325 |
Dr. Daiquirie Crumrine, PHD, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5015 E. 29th Street North, 'entrance T', Wichita, KS 67220 Phone: 316-978-3289 Fax: 316-978-7264 |
Emily D Foerschler, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8700 E 29th St N, Wichita, KS 67226 Phone: 316-634-8710 Fax: 316-634-8850 |
Gina Riggs, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5015 E 29th St N, Door T, Wichita, KS 67220 Phone: 316-978-3289 Fax: 316-978-7264 |
Mrs. Holly Marie Nelson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8700 E 29th St N, Wichita, KS 67226 Phone: 316-634-8710 |
Ms. Teresa S Harris, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 340 S Broadway St, Wichita, KS 67202 Phone: 316-267-5437 Fax: 316-267-5444 |
Sophia Johnson Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 940 N Tyler Rd Ste 201, Wichita, KS 67212 Phone: 316-295-6845 |
Kylea Schrag, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1315 N Sheridan St Apt 24, Wichita, KS 67203 Phone: 316-650-9480 |
Ms. Cheryl K Davis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 340 S Broadway St, Wichita, KS 67202 Phone: 316-267-5437 Fax: 316-267-5444 |
Mrs. Stephanie Marie Rozendal, MA-CCC SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5550 E Kelloge Ave, Wichita, KS 67218 Phone: 316-685-2221 |
Holly D Taylor Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1999 N Amidon Ave Ste 110, Wichita, KS 67203 Phone: 316-768-6718 Fax: 316-768-6718 |
Tanner Jordan Staab Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3636 N Ridge Rd, Wichita, KS 67205 Phone: 316-462-3636 |
Lauren Kirk Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 240 N Pinecrest St, Wichita, KS 67208 Phone: 316-258-4940 |
Janette Warne, MA,CCC,C SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5015 E 29th St N, Wichita, KS 67220 Phone: 316-978-3289 Fax: 316-978-7264 |
News Archive
The Natural Sciences and Engineering Research Council of Canada (NSERC) supports research that results in "breakthrough answers to timeless questions." When choosing awardees, the council looks for creativity and innovation, two qualities they see at the heart of all research advances.
TWi Biotechnology Inc. today announced interim results from the ongoing Phase 2 proof of concept clinical study evaluating AC-201 CR as an oral uricosuric and anti-inflammatory agent for the treatment of hyperuricemia and prevention of gout flares combining with febuxostat, a xanthine oxidase inhibitor.
A team of American and Italian neuroscientists has identified a cellular change in the brain that accompanies obesity. The findings could explain the body's tendency to maintain undesirable weight levels, rather than an ideal weight, and identify possible targets for pharmacological efforts to address obesity.
MOCON, Inc. announced today that on February 17, 2011, its Board of Directors declared a quarterly cash dividend of ten cents ($0.10) per share, payable on May 20, 2011, to shareholders of record on May 6, 2011. This is a five percent increase over the previous rate of nine and one-half cents per share.
Emergency angioplasty (balloondilation of the coronary vessel) is the preferred treatment for patients with an acute heart attack. Because of its limited availability worldwide, the majority of patients who are admitted to the hospital with a heart-attack are treated with clot-lysing drugs (thrombolysis).
› Verified 5 days ago